Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis

Madeleine Duvic, Michael T. Tetzlaff, Pamela Gangar, Audra L. Clos, Dawen Sui, Rakhshandra Talpur

Research output: Contribution to journalArticlepeer-review

151 Scopus citations

Fingerprint Dive into the research topics of 'Results of a phase II trial of brentuximab vedotin for CD30<sup>+</sup> cutaneous T-cell lymphoma and lymphomatoid papulosis'. Together they form a unique fingerprint.

Medicine & Life Sciences